Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists

Recruiting now · Not applicable

Conditions studied: Chronic Pain

In brief

DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.

Key facts

Study ID

NCT06052384

Run by

Centre Hospitalier Emile Roux

People needed

664

Starts

2023-12-07

Expected to finish

2027-06-01

Last updated by the study team

2025-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• First consultation at the pain management center
• Patient with chronic pain as defined by the "Haute Autorité de Santé". The pain must have several of the following characteristics:
• Persistence or recurrence
• Duration beyond what is usual for the presumed initial cause, especially if the pain has been evolving for more than 3 months;
• Inadequate response to treatment;
• Important and progressive deterioration of the patient's functional and interpersonal abilities in activities of daily living at home, school, or work due to the pain.
• Patients with chronic primary pain (according to the typology defined by the International Classification of Diseases-11) and classified into one of the 4 following categories:
• Chronic generalized pain
• Complex regional pain syndrome
• Chronic primary headache or orofacial pain
• Chronic primary musculoskeletal pain
• Pittsburgh Sleep Quality Index (PSQI) must be completed by the patient and the score must be available (for randomization purposes)
• Have access to an internet connection as a self-administered questionnaire is to complete online, and at least have access to the online platform for CBT treatment if insomnia is detected
• Affiliation to a French social security system
• Free informed consent

You may not qualify if…

• Patients undergoing cancer treatment or who have completed treatment within the last 2 years
• Patient with a chronic inflammatory disease (e.g. rheumatoid arthritis, ankylosing spondylitis, chronic inflammatory bowel disease, Horton's disease, Wegener's disease, myositis, Still's disease, lupus erythematosus, etc.)
• Immunocompromised patient
• Patient with severe psychiatric pathology that does not allow study follow-up (at the discretion of the investigator)
• Patient already treated for a sleep disorder by a sleep specialist (the only prescription of hypnotics is not considered as a criterion of non-inclusion)
• Patient follow-up difficult (for geographic motives or other reasons)
• Patient under judicial protection of incapable adults or guardianship
• Refusal to participate in the research

Where it is running

• Centre Hospitalier Emile Roux — Le Puy-en-Velay, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.